The global dendritic cell cancer vaccine immunotherapy market is growing at a CAGR of 14.4% over the forecast period (2021 – 2030)
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |